Kurt Fernstrom

Array ( [id] => 8659049 [patent_doc_number] => 20130039878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'TRIPLE CROSS-LINKED COLLAGEN, METHOD OF MANUFACTURING THE SAME, AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/443115 [patent_app_country] => US [patent_app_date] => 2012-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9130 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13443115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10008041 [patent_doc_number] => 09051547 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing' [patent_app_type] => utility [patent_app_number] => 13/428996 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 10605 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9546716 [patent_doc_number] => 20140171365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'PEGYLATED HUMAN HDL PARTICLE AND PROCESS FOR PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 14/007289 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13322 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363706 [patent_doc_number] => 20140073577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'POTENT AND SELECTIVE INHIBITORS OF NAV1.3 AND NAV1.7' [patent_app_type] => utility [patent_app_number] => 14/005135 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 127 [patent_figures_cnt] => 127 [patent_no_of_words] => 143569 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11561735 [patent_doc_number] => 09624307 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs' [patent_app_type] => utility [patent_app_number] => 14/003963 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 18520 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9635554 [patent_doc_number] => 20140213663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'ICE CRYSTALLIZATION INHIBITOR DERIVED FROM PLANT SEED' [patent_app_type] => utility [patent_app_number] => 14/002849 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8871 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9140091 [patent_doc_number] => 08580548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-12 [patent_title] => 'Production of nucleic acid' [patent_app_type] => utility [patent_app_number] => 13/408732 [patent_app_country] => US [patent_app_date] => 2012-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29583 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13408732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192000 [patent_doc_number] => 20130331315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'Protein Hydrolysate Compositions Having Enhanced CCK and GLP-1 Releasing Activity' [patent_app_type] => utility [patent_app_number] => 14/001292 [patent_app_country] => US [patent_app_date] => 2012-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19053 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11596853 [patent_doc_number] => 09644006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-09 [patent_title] => 'Carrier peptides for cell delivery' [patent_app_type] => utility [patent_app_number] => 13/985747 [patent_app_country] => US [patent_app_date] => 2012-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 13 [patent_no_of_words] => 19112 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10953263 [patent_doc_number] => 20140356284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'HYDROPHOBIC MODIFIED PEPTIDES FOR LIVER SPECIFIC DIAGNOSIS' [patent_app_type] => utility [patent_app_number] => 13/984715 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12179 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9148918 [patent_doc_number] => 20130303441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'GLYCOGEN SYNTHASE KINASE-3 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/982300 [patent_app_country] => US [patent_app_date] => 2012-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19165 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9108235 [patent_doc_number] => 20130281367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'Agent for Suppressing Elevation of Blood GIP Level, Agent for Suppressing Elevation of Blood Insulin Level, Agent for Lowering Blood Triglyceride Level After Meal Ingestion, and Agent for Suppressing Elevation of Blood Glucose Level' [patent_app_type] => utility [patent_app_number] => 13/996261 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12495 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8382302 [patent_doc_number] => 20120225929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'Nucleic Acid Inhibitors Of Glutamate Receptors' [patent_app_type] => utility [patent_app_number] => 13/323161 [patent_app_country] => US [patent_app_date] => 2011-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12011 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13323161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898300 [patent_doc_number] => 08921516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Synthetic, defined fibronectin mimetic peptides and surfaces modified with the same' [patent_app_type] => utility [patent_app_number] => 13/309756 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5971 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13309756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676898 [patent_doc_number] => 08815807 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Peptides and peptide compositions having osteoinductive activity' [patent_app_type] => utility [patent_app_number] => 13/309734 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 14236 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13309734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9262196 [patent_doc_number] => 20130344125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'DRUG DELIVERY DEVICE' [patent_app_type] => utility [patent_app_number] => 13/989402 [patent_app_country] => US [patent_app_date] => 2011-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9091 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882760 [patent_doc_number] => 08969524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'FVIII peptides for immune tolerance induction and immunodiagnostics' [patent_app_type] => utility [patent_app_number] => 13/283452 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31866 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13283452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976678 [patent_doc_number] => 20130210108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'METHOD FOR CONTROLLING THE CHAPERONE ACTIVITY OF PEROXIREDOXINS USING IRRADIATION' [patent_app_type] => utility [patent_app_number] => 13/881017 [patent_app_country] => US [patent_app_date] => 2011-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 8024 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313591 [patent_doc_number] => 20120190609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'METHOD FOR PRODUCING A LIPID PARTICLE, THE LIPID PARTICLE ITSELF AND ITS USE' [patent_app_type] => utility [patent_app_number] => 13/217536 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 25146 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13217536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8865538 [patent_doc_number] => 20130149241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'PEPTIDE RADIOTRACER COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/816589 [patent_app_country] => US [patent_app_date] => 2011-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12338 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816589 [rel_patent_id] =>[rel_patent_doc_number] =>)